Patents by Inventor Victoria M. Bedell

Victoria M. Bedell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS TO TREAT ULTRAVIOLET (UV)-INDUCED SKIN INJURY
    Publication number: 20210213137
    Abstract: This document relates to materials and methods for administering (e.g., topically administering) one or more vascular endothelial growth factor (VEGF) inhibitors to reduce and/or treat ultraviolet (UV)-induced skin injury. For example, compositions including one or more VEGF inhibitors that can be administered (e.g., topically administered) to a mammal to reduce and/or treat UV-induced skin injury following UV exposure are provided.
    Type: Application
    Filed: January 20, 2021
    Publication date: July 15, 2021
    Inventors: Stephen C. Ekker, Debabrata Mukhopadhyay, Priyabrata Mukherjee, Victoria M. Bedell, Luke H. Hoeppner, Stella P. Hartono
  • COMPOSITIONS TO TREAT ULTRAVIOLET (UV)-INDUCED SKIN INJURY
    Publication number: 20190336613
    Abstract: This document relates to materials and methods for administering (e.g., topically administering) one or more vascular endothelial growth factor (VEGF) inhibitors to reduce and/or treat ultraviolet (UV)-induced skin injury. For example, compositions including one or more VEGF inhibitors that can be administered (e.g., topically administered) to a mammal to reduce and/or treat UV-induced skin injury following UV exposure are provided.
    Type: Application
    Filed: September 21, 2017
    Publication date: November 7, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Stephen C. Ekker, Debabrata Mukhopadhyay, Priyabrata Mukherjee, Victoria M. Bedell, Luke H. Hoeppner, Stella P. Hartono
  • GENOME EDITING
    Publication number: 20150291951
    Abstract: This document provides materials and methods for editing a genome (e.g., an animal genome in vivo). For example, methods and materials for using a targeted endonuclease and a donor nucleic acid having a length within a particular range (e.g., from 20 to 95 nucleotides) to edit a genome are provided.
    Type: Application
    Filed: March 14, 2013
    Publication date: October 15, 2015
    Inventors: Stephen C. Ekker, Jarryd M. Campbell, Victoria M. Bedell